Article

Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panel

2023-12-21

Abstract excerpt

<h4>ABSTRACT</h4> Cancer poses a significant global health challenge, with increasing incidence rates demanding precise genomic testing for individualized treatment strategies. Targeted-panel sequencing (TPS) has improved personalized oncology but often lacks comprehensive coverage of crucial cancer alterations. Whole-genome sequencing (WGS) addresses this gap, offering extensive genomic testing. This study demons...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3efba7ab-bfcf-5c04-a850-03a5e3c4eef9
DOI: 10.1101/2023.12.20.23300156

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panelDOI 10.1101/2023.12.20.23300156Read

Utilizing Targeted Enhanced-Whole-Genome Sequencing in Precision Oncology for the Treatment of Solid Tumors: A Clinical PerspectiveSemantic proximity Read

Clinical application of whole-genome sequencing for precision oncology of solid tumorsSemantic proximity Read

Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test.Semantic proximity Read

Analytical and clinical validation of a targeted-enhanced whole genome sequencing-based comprehensive genomic profiling testSemantic proximity Read

Applications and analysis of targeted genomic sequencing in cancer studiesSemantic proximity Read

Analytical demands to use whole-genome sequencing in precision oncologySemantic proximity Read

Clinical application of whole-genome sequencing of solid tumors for precision oncology.Semantic proximity Read

Comparison of Whole Genome Sequencing with Clinical Targeted Panel Sequencing of Metastatic Prostate Cancer: Insights from Real- World DataSemantic proximity Read

Clinical application of tumour whole genome sequencing in routine molecular diagnostics for solid cancer patientsSemantic proximity Read

Comparison of whole genome sequencing with clinical targeted panel sequencing of metastatic prostate cancer: insights from real-world dataSemantic proximity Read

TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted SequencingSemantic proximity Read

From Genomic Exploration to Personalized Treatment: Next-Generation Sequencing in OncologySemantic proximity Read